Annual Report

Overview

The report presents PuraPharm's 2019 ESG activities across its Hong Kong and PRC operations, while excluding the United States and Japan because their environmental and social impacts were considered insignificant and immaterial. It identifies 24 key ESG topics through a stakeholder survey with 66 responses and reports 2019 Scope 1 and Scope 2 emissions alongside energy, water and waste information.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Publication date: 24 March 2020
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services